A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ED / early death

[Related PubMed/MEDLINE]
Total Number of Papers: 63
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ED  (>> Co-occurring Abbreviation)
Long Form:   early death
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Assessing the characteristics and feasibility of preventing early mortality in patients with hepatocellular carcinoma. HCC, TNM
2019 Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group. AML, DCOG, TRM
2019 Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide. APL, WBC
2019 Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG). BM, CLAM, PALG, pts
2019 Early Mortality in Children and Adolescents with Acute Promyelocytic Leukemia: Experience of the Boldrini Children's Center. APL, CI
2019 Factors Affecting Early Death and Survival of Patients With Acute Promyelocytic Leukemia Treated With ATRA-Based Therapy Regimens. ATRA, HR
2019 Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience. APL, PALG
2019 Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country. AML, AML-DS, APL, LMICs
2019 The Factors Affecting Early Death in Newly Diagnosed APL Patients. AML, APL
10  2019 The Role of Abnormal Hemostasis and Fibrinolysis in Morbidity and Mortality of Acute Promyelocytic Leukemia. APL, tPA
11  2019 Toward Candidate Proteomic Biomarkers in Clinical Monitoring of Acute Promyelocytic Leukemia Treatment with Arsenic Trioxide. APL, ATO, CR
12  2018 Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia. APL, ATO, ATRA, CR
13  2018 Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death. APL
14  2018 Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia. APL, WBC
15  2018 Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period. CODs, LD, SLE
16  2018 Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia. APL, APTT, LDH, PLT, PT, WBC
17  2018 The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia. APL, ATO, ATRA, DIC
18  2017 Analysis of early death in newly diagnosed acute promyelocytic leukemia patients. APL, ISTH, PT
19  2017 Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide. APL, ATO, DS, ECOG
20  2017 Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE). APL, DS, UAE
21  2017 Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials. AML, TRM
22  2017 Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis. AEs, AML, CI, CR, ORR, OS
23  2017 Multisensory emotion perception in congenitally, early, and late deaf CI users. CD, CI, LD
24  2017 Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. APL, ATRA, PB, TH, WBC
25  2016 Cardiac phenotype determines survival in Duchenne muscular dystrophy. DMD, EF, PS
26  2016 Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis. ET, FAB, LPh, WBC
27  2016 Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group. ALL, CR, DFS, OS, Ph
28  2016 HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants. AML, CAG, CR, HAG, MDS
29  2016 Risk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasis. CRC, CRCLM, ER
30  2016 [Clinical features and prognostic analysis of high-risk acute promyelocytic leukemia patients]. APL, CNS, CR, OS, RFS
31  2015 Central nervous system haemorrhage causing early death in acute promyelocytic leukaemia. APL, ATRA, DIC, PML-RARalpha
32  2015 [The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients]. APL, ATO, ATRA, CR, CT, OS, RFS
33  2014 Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study. APL, CCR, OS
34  2014 Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: final results of a multicentric study in the United States. APL, ATRA
35  2014 Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. APL, ATRA, DS, WBC
36  2014 Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort. APL, DIC
37  2014 [Characteristics and treatment outcomes in 822 adult patients with acute myeloid leukemia:a single center experience]. AML, DFS, OS
38  2013 Clinical characteristics of acute promyelocytic leukemia manifesting as early death. APL, WBC
39  2013 Early Death in Two Patients with Acute Promyelocytic Leukemia Presenting the bcr3 Isoform, FLT3-ITD Mutation, and Elevated WT1 Level. APL
40  2013 Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL). APL, CR, OS
41  2013 International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia. APL
42  2013 Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial. AML, CR, EFS, OS
43  2011 Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. AML, APL
44  2010 Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. CR
45  2010 Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003. AML, NOPHO, TRD
46  2010 Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. AML, LDH, WBC
47  2010 Problem solved: erectile dysfunction (ED) = early death (ED). ---
48  2009 Resectable pancreatic cancer: who really benefits from resection? ---
49  2007 [Long-term therapeutic outcome of patients with acute promyelocytic leukemia]. APL, OS, RFS
50  2004 Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. AML, AML-BFM, TRM
51  2002 The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study. AML, CR, PALG, TRM
52  2001 Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969-1999. CR, RD, SBH
53  2001 Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. CLB, LY, MBC series, NHL
54  2000 Prognosis of patients with a second relapse of acute myeloid leukemia. AML, BMT, CR, CT, OS
55  1999 De novo and secondary acute myeloid leukemia in patients over the age of 65: a review of fifty-six successive and unselected cases from a general hospital. MS, sAML
56  1998 Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison. AML, NR, PR, S-HAM
57  1995 In vitro drug sensitivity of leukemic progenitors and P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome. AML, Ara-C, CR, DNR, P-gp, RL
58  1994 Relationship between shell porosity, shell thickness, egg weight loss, and embryonic development in Japanese quail eggs. LD, PIP
59  1993 High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group). ER, LEY-TAS
60  1991 Survival factors in a canine septic shock model. LDS
61  1991 Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases. AMSA, APL, CR, DFS, DNR, HD, MTX
62  1985 Acute promyelocytic leukemia in 57 previously untreated patients. APL, CR, DA, DIC
63  1985 Factors related to early deaths (ED) in children with acute lymphoblastic leukemia (ALL) ALL